查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1492409

黏液囊炎治疗市场：按类型、药物类型、最终用户划分 - 全球预测 2024-2030

Bursitis Treatment Market by Type (Acute Bursitis, Chronic Bursitis), Drug Type (Medication, Physical Therapy), End-User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

黏液囊炎治疗市场规模预计到2023年为78.1亿美元，2024年达到81.4亿美元，预计2030年将达到106.9亿美元，复合年增长率为4.58%。

黏液囊炎是一种以发炎或发炎为特征的疾病，滑囊是关节附近充满液体的小囊。滑囊可作为缓衝垫，减少骨骼与肌肉、肌腱和皮肤等运动部位之间的摩擦。当这些囊发炎时，受影响的区域会感到疼痛、肿胀和活动受限。黏液囊炎治疗是指当滑囊发炎时，黏液囊炎引起的发炎和疼痛的各种方法。关节炎、痛风和糖尿病等肌肉骨骼疾病的增加增加了黏液囊炎的风险。对这种疾病的更好了解和增加医疗基础设施投资正在促进市场扩张。然而，黏液囊炎的症状往往与其他关节疾病相似，这可能导致误诊和治疗无效。此外，新兴国家正在发展医疗基础设施，为黏液囊炎治疗创造了新的市场。诊断工具和治疗方案的改进可以带来更有效、更快的结果，从而增加市场成长机会。

主要市场统计
基准年[2023] 78.1亿美元
预测年份 [2024] 81.4亿美元
预测年份 [2030] 106.9亿美元
复合年增长率（%） 4.58%

区域洞察

美国肌肉骨骼疾病的盛行率很高，是黏液囊炎治疗的重要市场。先进的医疗基础设施、对该疾病的广泛认识以及积极参与导致运动伤害的运动，导致对有效治疗的需求不断增长。该市场的特点是存在大量投资于研发的大型製药企业。美国正在进行的创新主要集中在新型发炎药物和微创外科手术上，以确保更快的康復和更少的副作用。在欧盟国家，人口老化和运动的普及正在创造对黏液囊炎治疗的强劲需求。整个欧盟的医疗保健法规和政策强调安全有效的治疗，将研究引向更安全的药物干预和物理治疗技术。欧盟资助的计划通常着重于在更广泛的健康倡议下改善肌肉骨骼疾病（包括黏液囊炎）的诊断和治疗。中东治疗市场正在成长，并受到医疗设施改善和可支配收入增加的影响。亚太地区人口众多且老年人口不断增加，是黏液囊炎治疗的一个值得注意的市场。政府对医疗改革和提高老龄化社会生活品质的支持正在刺激研究和发展。

FPNV定位矩阵

FPNV 定位矩阵对于评估黏液囊炎治疗市场供应商的市场定位至关重要。此矩阵提供了对供应商的全面评估，并检查了与商务策略和产品满意度相关的关键指标。这种详细的评估使用户能够根据自己的要求做出明智的决定。根据评估结果，供应商被分为代表其成功程度的四个像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对黏液囊炎治疗市场供应商的现状进行深入而详细的评估。透过仔细比较和分析供应商的贡献，您可以更深入地了解每个供应商的绩效以及他们在争夺市场占有率时面临的挑战。这些贡献包括整体收益、客户群和其他重要指标。此外，该分析还提供了对该行业竞争性质的宝贵见解，包括在研究基准年期间观察到的累积、分散主导地位和合併特征等因素。有了这些详细信息，供应商可以做出更明智的决策并製定有效的策略，以在市场竞争中保持领先地位。

策略分析与建议

策略分析对于寻求在全球市场站稳脚跟的组织至关重要。对黏液囊炎治疗市场当前地位的全面评估使公司能够做出符合其长期愿望的明智决策。此关键评估涉及对组织的资源、能力和整体绩效进行彻底分析，以确定核心优势和需要改进的领域。

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球肌肉骨骼疾病的发生率正在增加
      • 提高对卫生基础设施的认识和投资
    • 抑制因素
      • 政府对药品核准的严格规定
    • 机会
      • 黏液囊炎诊断工具和治疗方案的进展
      • 药物研发配方持续创新
    • 任务
      • 诊断复杂且缺乏报销政策
  • 市场区隔分析
    • 类型：慢性黏液囊炎有利于解决疼痛管理和预防进一步关节损伤的治疗
    • 最终使用者：医院和诊所可以轻鬆获得急性黏液囊炎所需的即时治疗。
  • 市场扰动分析
  • 波特五力分析
  • 价值炼和关键路径分析
  • 价格分析
  • 技术分析
  • 专利分析
  • 贸易分析
  • 法规结构分析

第六章黏液囊炎治疗市场：依类型

  • 急性黏液囊炎
  • 慢性黏液囊炎

第七章依药物类型分類的黏液囊炎治疗市场

  • 药物治疗
  • 物理治疗

第八章黏液囊炎治疗市场：依最终用户分类

  • 医院/诊所
  • 復健中心

第九章北美和南美黏液囊炎治疗市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太黏液囊炎治疗市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲的黏液囊炎治疗市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • 远藤製药推出非专利药 Duexis“Ibuprofen/法莫替丁片”
    • FDA核准创新皮质类固醇治疗Duchenne氏肌肉失养症
  • 战略分析和建议

第13章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-5D693B46C73C

[195 Pages Report] The Bursitis Treatment Market size was estimated at USD 7.81 billion in 2023 and expected to reach USD 8.14 billion in 2024, at a CAGR 4.58% to reach USD 10.69 billion by 2030.

Bursitis is a medical condition characterized by inflammation or irritation of a bursa, which is a small fluid-filled sac located near the joints. Bursae function as cushions, reducing friction between the bones and other moving parts, including muscles, tendons, and skin. When these sacs become inflamed, the affected area can experience pain, swelling, and restricted movement. Bursitis treatment refers to the various methods used to loosen the inflammation and pain caused by bursitis, a condition where the bursae become inflamed. Increases in the incidence of musculoskeletal disorders, including arthritis, gout, and diabetes, escalate the risk of developing bursitis. Enhanced understanding of the condition and greater investment in health infrastructure contribute to market expansion. However, bursitis symptoms often mimic those of other joint disorders, potentially leading to misdiagnosis and ineffective treatments. Furthermore, developing regions are observing increased healthcare infrastructure, presenting new markets for bursitis treatments. Improved diagnostic tools and treatment options enhance market growth opportunities by providing more effective and faster results.

KEY MARKET STATISTICS
Base Year [2023] USD 7.81 billion
Estimated Year [2024] USD 8.14 billion
Forecast Year [2030] USD 10.69 billion
CAGR (%) 4.58%

Regional Insights

The United States is a significant market for bursitis treatment due to a high prevalence of musculoskeletal conditions. Advanced healthcare infrastructure, widespread awareness about the condition, and active participation in sports leading to sports injuries contribute to a higher demand for effective treatments. The market is characterized by the presence of leading pharmaceutical companies investing heavily in research and development. Ongoing innovation in the United States focuses on novel anti-inflammatory drugs and minimally invasive surgical procedures that promise faster recovery and fewer side effects. EU countries show a strong demand for bursitis treatments driven by an aging population and a high rate of sports activities. Regulations and healthcare policies across the EU emphasize safe and effective treatments, steering research towards safer pharmacological interventions and physiotherapy techniques. EU-funded projects often focus on improving diagnosis and treatments for musculoskeletal disorders, including bursitis, under broader health initiatives. The treatment market in the Middle East is growing and is influenced by improving healthcare facilities and increasing disposable incomes. APAC, with a large population and increasing elderly demographic, makes it a noteworthy market for bursitis treatments. The government's push towards healthcare reform and enhancing the quality of life for the aging population has fueled research and development.

Market Insights

  • Market Dynamics

The market dynamics represent an ever-changing landscape of the Bursitis Treatment Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

    • Market Drivers
      • Rising incidence of musculoskeletal disorders globally
      • Increased awareness coupled with rising investment in health infrastructure
    • Market Restraints
      • Strict government regulations regarding drug approval
    • Market Opportunities
      • Advancements in diagnostic tools and treatment options in bursitis
      • Ongoing innovation in drug development formulations
    • Market Challenges
      • Complexities associated with diagnostic and lack of reimbursement policies
  • Market Segmentation Analysis
    • Type: Chronic bursitis prefer treatments to address pain management and prevention of further joint damage
    • End-User: Hospitals and clinics offer better accessibility for the immediate care required for acute bursitis
  • Market Disruption Analysis
  • Porter's Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Bursitis Treatment Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Bursitis Treatment Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Endo Pharmaceuticals Introduces Generic Version of Duexis: Ibuprofen-Famotidine Tablets

Endo Pharmaceuticals has launched a new generic medication containing ibuprofen and famotidine, which serves as a counterpart to the branded drug Duexis. This new generic product is specifically formulated to simultaneously alleviate pain and reduce the risk of stomach ulcers, addressing the dual needs of patients who require nonsteroidal anti-inflammatory drugs (NSAIDs) for conditions such as bursitis while safeguarding their gastrointestinal health. [Published On: 2024-03-26]

FDA Greenlights Innovative Corticosteroid for Duchenne Muscular Dystrophy Management

The U.S. Food and Drug Administration (FDA) has approved a new corticosteroid treatment for patients with Duchenne Muscular Dystrophy (DMD). This novel therapeutic option is designed to provide the benefits of traditional corticosteroid therapy but with reduced adverse effects. This approval marks a significant advancement in managing DMD, offering a more tolerable and potentially effective treatment alternative. [Published On: 2023-10-27]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Bursitis Treatment Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Bursitis Treatment Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Amgen Inc., Arinna Lifesciences Ltd., AstraZeneca PLC, Bioanalytical Systems, Inc., Bristol-Myers Squibb Company, Crescent Formulations Pvt.Ltd., Eli Lilly and Company, F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Johnson & Johnson Services, Inc., Merck & Co., Inc., NIDEK CO., LTD., Novartis AG, Perrigo Company PLC, Pfizer Inc., Sanofi S.A., Sun Pharmaceutical Industries Limited, Teva Pharmaceutical Industries Ltd., and Topcon Corporation.

Market Segmentation & Coverage

This research report categorizes the Bursitis Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Acute Bursitis
    • Chronic Bursitis
  • Drug Type
    • Medication
      • Corticosteroids
      • Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
      • Physical Therapy
    • Physical Therapy
  • End-User
    • Hospitals & Clinics
    • Rehabilitation Centers
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidence of musculoskeletal disorders globally
      • 5.1.1.2. Increased awareness coupled with rising investment in health infrastructure
    • 5.1.2. Restraints
      • 5.1.2.1. Strict government regulations regarding drug approval
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in diagnostic tools and treatment options in bursitis
      • 5.1.3.2. Ongoing innovation in drug development formulations
    • 5.1.4. Challenges
      • 5.1.4.1. Complexities associated with diagnostic and lack of reimbursement policies
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Chronic bursitis prefer treatments to address pain management and prevention of further joint damage
    • 5.2.2. End-User: Hospitals and clinics offer better accessibility for the immediate care required for acute bursitis
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Bursitis Treatment Market, by Type

  • 6.1. Introduction
  • 6.2. Acute Bursitis
  • 6.3. Chronic Bursitis

7. Bursitis Treatment Market, by Drug Type

  • 7.1. Introduction
  • 7.2. Medication
  • 7.3. Physical Therapy

8. Bursitis Treatment Market, by End-User

  • 8.1. Introduction
  • 8.2. Hospitals & Clinics
  • 8.3. Rehabilitation Centers

9. Americas Bursitis Treatment Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Bursitis Treatment Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Bursitis Treatment Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Endo Pharmaceuticals Introduces Generic Version of Duexis: Ibuprofen-Famotidine Tablets
    • 12.3.2. FDA Greenlights Innovative Corticosteroid for Duchenne Muscular Dystrophy Management
  • 12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. BURSITIS TREATMENT MARKET RESEARCH PROCESS
  • FIGURE 2. BURSITIS TREATMENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BURSITIS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. BURSITIS TREATMENT MARKET DYNAMICS
  • FIGURE 7. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS BURSITIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS BURSITIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES BURSITIS TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES BURSITIS TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC BURSITIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC BURSITIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BURSITIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BURSITIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. BURSITIS TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. BURSITIS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BURSITIS TREATMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BURSITIS TREATMENT MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL BURSITIS TREATMENT MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY ACUTE BURSITIS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY ACUTE BURSITIS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY CHRONIC BURSITIS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY CHRONIC BURSITIS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY PHYSICAL THERAPY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY PHYSICAL THERAPY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY PHYSICAL THERAPY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY PHYSICAL THERAPY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY REHABILITATION CENTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY REHABILITATION CENTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. AMERICAS BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 34. AMERICAS BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 35. AMERICAS BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 36. AMERICAS BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 37. AMERICAS BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 38. AMERICAS BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 39. AMERICAS BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 40. AMERICAS BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 41. AMERICAS BURSITIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 42. AMERICAS BURSITIS TREATMENT MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 43. ARGENTINA BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 44. ARGENTINA BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 45. ARGENTINA BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 46. ARGENTINA BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 47. ARGENTINA BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 48. ARGENTINA BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 49. ARGENTINA BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 50. ARGENTINA BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 51. BRAZIL BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 52. BRAZIL BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 53. BRAZIL BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 54. BRAZIL BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 55. BRAZIL BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 56. BRAZIL BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 57. BRAZIL BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 58. BRAZIL BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 59. CANADA BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 60. CANADA BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 61. CANADA BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 62. CANADA BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 63. CANADA BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 64. CANADA BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 65. CANADA BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 66. CANADA BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 67. MEXICO BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 68. MEXICO BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 69. MEXICO BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 70. MEXICO BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 71. MEXICO BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 72. MEXICO BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 73. MEXICO BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 74. MEXICO BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 75. UNITED STATES BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 76. UNITED STATES BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 77. UNITED STATES BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 78. UNITED STATES BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 79. UNITED STATES BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 80. UNITED STATES BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 81. UNITED STATES BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 82. UNITED STATES BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 83. UNITED STATES BURSITIS TREATMENT MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 84. UNITED STATES BURSITIS TREATMENT MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC BURSITIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC BURSITIS TREATMENT MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 95. AUSTRALIA BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 96. AUSTRALIA BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 97. AUSTRALIA BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 98. AUSTRALIA BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 99. AUSTRALIA BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 100. AUSTRALIA BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 101. AUSTRALIA BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 102. AUSTRALIA BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 103. CHINA BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 104. CHINA BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 105. CHINA BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 106. CHINA BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 107. CHINA BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 108. CHINA BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 109. CHINA BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 110. CHINA BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 111. INDIA BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 112. INDIA BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 113. INDIA BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 114. INDIA BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 115. INDIA BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 116. INDIA BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 117. INDIA BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 118. INDIA BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 119. INDONESIA BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 120. INDONESIA BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 121. INDONESIA BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 122. INDONESIA BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 123. INDONESIA BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 124. INDONESIA BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 125. INDONESIA BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 126. INDONESIA BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 127. JAPAN BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 128. JAPAN BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 129. JAPAN BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 130. JAPAN BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 131. JAPAN BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 132. JAPAN BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 133. JAPAN BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 134. JAPAN BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 135. MALAYSIA BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 136. MALAYSIA BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 137. MALAYSIA BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 138. MALAYSIA BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 139. MALAYSIA BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 140. MALAYSIA BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 141. MALAYSIA BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 142. MALAYSIA BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 143. PHILIPPINES BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 144. PHILIPPINES BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 145. PHILIPPINES BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 146. PHILIPPINES BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 147. PHILIPPINES BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 148. PHILIPPINES BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 149. PHILIPPINES BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 150. PHILIPPINES BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 151. SINGAPORE BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 152. SINGAPORE BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 153. SINGAPORE BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 154. SINGAPORE BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 155. SINGAPORE BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 156. SINGAPORE BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 157. SINGAPORE BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 158. SINGAPORE BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 159. SOUTH KOREA BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 160. SOUTH KOREA BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 161. SOUTH KOREA BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 162. SOUTH KOREA BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 163. SOUTH KOREA BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 164. SOUTH KOREA BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 165. SOUTH KOREA BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 166. SOUTH KOREA BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 167. TAIWAN BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 168. TAIWAN BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 169. TAIWAN BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 170. TAIWAN BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 171. TAIWAN BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 172. TAIWAN BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 173. TAIWAN BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 174. TAIWAN BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 175. THAILAND BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 176. THAILAND BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 177. THAILAND BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 178. THAILAND BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 179. THAILAND BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 180. THAILAND BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 181. THAILAND BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 182. THAILAND BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 183. VIETNAM BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 184. VIETNAM BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 185. VIETNAM BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 186. VIETNAM BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 187. VIETNAM BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 188. VIETNAM BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 189. VIETNAM BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 190. VIETNAM BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 191. EUROPE, MIDDLE EAST & AFRICA BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 192. EUROPE, MIDDLE EAST & AFRICA BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 193. EUROPE, MIDDLE EAST & AFRICA BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 194. EUROPE, MIDDLE EAST & AFRICA BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 195. EUROPE, MIDDLE EAST & AFRICA BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 196. EUROPE, MIDDLE EAST & AFRICA BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA BURSITIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA BURSITIS TREATMENT MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 201. DENMARK BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 202. DENMARK BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 203. DENMARK BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 204. DENMARK BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 205. DENMARK BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 206. DENMARK BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 207. DENMARK BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 208. DENMARK BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 209. EGYPT BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 210. EGYPT BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 211. EGYPT BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 212. EGYPT BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 213. EGYPT BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 214. EGYPT BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 215. EGYPT BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 216. EGYPT BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 217. FINLAND BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 218. FINLAND BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 219. FINLAND BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 220. FINLAND BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 221. FINLAND BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 222. FINLAND BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 223. FINLAND BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 224. FINLAND BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 225. FRANCE BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 226. FRANCE BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 227. FRANCE BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 228. FRANCE BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 229. FRANCE BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 230. FRANCE BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 231. FRANCE BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 232. FRANCE BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 233. GERMANY BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 234. GERMANY BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 235. GERMANY BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 236. GERMANY BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 237. GERMANY BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 238. GERMANY BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 239. GERMANY BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 240. GERMANY BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 241. ISRAEL BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 242. ISRAEL BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 243. ISRAEL BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 244. ISRAEL BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 245. ISRAEL BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 246. ISRAEL BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 247. ISRAEL BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 248. ISRAEL BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 249. ITALY BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 250. ITALY BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 251. ITALY BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 252. ITALY BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 253. ITALY BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 254. ITALY BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 255. ITALY BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 256. ITALY BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 257. NETHERLANDS BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 258. NETHERLANDS BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 259. NETHERLANDS BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 260. NETHERLANDS BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 261. NETHERLANDS BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 262. NETHERLANDS BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 263. NETHERLANDS BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 264. NETHERLANDS BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 265. NIGERIA BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 266. NIGERIA BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 267. NIGERIA BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 268. NIGERIA BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 269. NIGERIA BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 270. NIGERIA BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 271. NIGERIA BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 272. NIGERIA BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 273. NORWAY BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 274. NORWAY BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 275. NORWAY BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 276. NORWAY BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 277. NORWAY BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 278. NORWAY BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 279. NORWAY BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 280. NORWAY BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 281. POLAND BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 282. POLAND BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 283. POLAND BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 284. POLAND BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 285. POLAND BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 286. POLAND BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 287. POLAND BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 288. POLAND BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 289. QATAR BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 290. QATAR BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 291. QATAR BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 292. QATAR BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 293. QATAR BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 294. QATAR BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 295. QATAR BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 296. QATAR BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 297. RUSSIA BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 298. RUSSIA BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 299. RUSSIA BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 300. RUSSIA BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 301. RUSSIA BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 302. RUSSIA BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 303. RUSSIA BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 304. RUSSIA BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 305. SAUDI ARABIA BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 306. SAUDI ARABIA BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 307. SAUDI ARABIA BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 308. SAUDI ARABIA BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 309. SAUDI ARABIA BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 310. SAUDI ARABIA BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 311. SAUDI ARABIA BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 312. SAUDI ARABIA BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 313. SOUTH AFRICA BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 314. SOUTH AFRICA BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 315. SOUTH AFRICA BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 316. SOUTH AFRICA BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 317. SOUTH AFRICA BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 318. SOUTH AFRICA BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 319. SOUTH AFRICA BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 320. SOUTH AFRICA BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 321. SPAIN BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 322. SPAIN BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 323. SPAIN BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 324. SPAIN BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 325. SPAIN BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 326. SPAIN BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 327. SPAIN BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 328. SPAIN BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 329. SWEDEN BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 330. SWEDEN BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 331. SWEDEN BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 332. SWEDEN BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 333. SWEDEN BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 334. SWEDEN BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 335. SWEDEN BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 336. SWEDEN BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 337. SWITZERLAND BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 338. SWITZERLAND BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 339. SWITZERLAND BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 340. SWITZERLAND BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 341. SWITZERLAND BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 342. SWITZERLAND BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 343. SWITZERLAND BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 344. SWITZERLAND BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 345. TURKEY BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 346. TURKEY BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 347. TURKEY BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 348. TURKEY BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 349. TURKEY BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 350. TURKEY BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 351. TURKEY BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 352. TURKEY BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 353. UNITED ARAB EMIRATES BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 354. UNITED ARAB EMIRATES BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 355. UNITED ARAB EMIRATES BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 356. UNITED ARAB EMIRATES BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 357. UNITED ARAB EMIRATES BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 358. UNITED ARAB EMIRATES BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2024-2030 (USD MILLION)
  • TABLE 359. UNITED ARAB EMIRATES BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 360. UNITED ARAB EMIRATES BURSITIS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 361. UNITED KINGDOM BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 362. UNITED KINGDOM BURSITIS TREATMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 363. UNITED KINGDOM BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 364. UNITED KINGDOM BURSITIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 365. UNITED KINGDOM BURSITIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2023 (USD MILLION)
  • TABLE 366. U